Biocon LtdPharmaceuticalsINE376G01013Consolidated₹385.00+5.00 (+1.32%)Jun-26
Valuation
Market Cap₹62.74K Cr
TTM PE113.24x
Forward PE105.38x
PEG5.18
Book Value₹208.82
P/B1.84x
TTM EPS₹3.40
Fwd EPS₹3.65
TTM Revenue₹17.32K Cr
TTM PAT₹416.40 Cr
TTM EBITDA₹3.54K Cr
TTM EBIT₹1.49K Cr
Last Qtr PAT₹136.80 Cr
Last Qtr EBITDA₹847.20 Cr
Last Qtr EBIT₹299.80 Cr
Profitability
ROE1.22%
ROCE2.98%
TTM NPM2.40%
TTM EBITDA %20.42%
Curr OPM3.12%
Last OPM4.35%
Curr NPM
Last NPM
Curr EPS₹0.87
Last EPS₹0.79
Balance sheet
Equity₹810.50 Cr
Reserve₹33.22K Cr
Total Debt₹15,434.10 Cr
D/E0.45x
Interest %155.85%
Curr Interest₹213.20 Cr
Price / range
Close₹385.00
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+1.32%
1W-1.45%
1M-7.78%
3M-6.97%
6M+0.71%
1Y+4.52%
2Y+5.87%
3Y+41.00%
5Y+2.01%
Diwali-0.71%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue624.50+16.3%604.70621.30583.30537.102,346.40
Other Income64.8049.8074.80133.8061.30319.70
Total Income689.30+15.2%654.50696.10717.10598.402,666.10
Interest17.3016.702.3067.2056.20142.40
Expenditure-619.40-2.2%-578.30-584.30-631.40-606-2,400
PBDT000000
EBITDA60.80+195.1%79.3073.3052.9020.60226.10
Depreciation-38.40-36.20-34-33.80-33.30-137.30
EBIT22.40+276.4%43.1039.3019.10-12.7088.80
PBT69.90+1019.7%57.40-84.5085.70-7.6051
Tax-17.70-6.408.10-14.80-0.70-13.80
Equity814.85810.50668.500668.50810.50
OPM10.148.77-12.1414.69-1.271.91
Net Profit52.20+728.9%51-76.4070.90-8.3037.20
NPM7.577.79-10.9812.15-1.391.40
EPS0.32+557.1%0.32-0.570.55-0.070.27

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,346.40+4.6%2,242.60+5.4%2,127.30+6.7%1,992.90+14.7%1,738.20-14.3%2,028.40
Other Income319.70242.30193271.40187.20150.20
Total Income2,666.10+7.3%2,484.90+7.1%2,320.30+2.5%2,264.30+17.6%1,925.40-11.6%2,178.60
Expenditure-2,400+1.3%-2,431.50-11.3%-2,184.50-1.3%-2,155.90-20.7%-1,785.70+1.9%-1,819.80
Interest-142.40-236.90-198.80-69.60-0.40-0.40
PBDT000000
EBITDA226.10+28.6%175.80-33.1%262.70+1017.9%23.50-61.5%61.10-80.4%312.50
Depreciation-137.30-127.80-121.10-116.90-108.20-103.50
EBIT88.80+85.0%48-66.1%141.60+251.6%-93.40-98.3%-47.10-122.5%209
PBT51-92.3%660.90+339.7%150.30-94.9%2,971.20+2026.8%139.70-61.1%358.80
Tax-13.80-51.60-31-122.80-53.60-78.30
Equity810.50600.300000
OPM (%)1.9126.606.00131.007.0016.00
Net Profit37.20-93.9%609.30+410.7%119.30-95.8%2,848.40+3208.2%86.10-69.3%280.50
NPM (%)1.4024.525.00126.004.0013.00
EPS (Rs)0.27-94.7%5.09+409.0%1-95.8%23.87+3215.3%0.72-69.5%2.36
CEPS0.275.09123.820.722.34

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue4,336+10.0%4,516.604,1734,295.503,941.9016,927
Other Income54.5052.50117.309379.70342.50
Total Income4,390.50+9.2%4,569.104,290.304,388.504,021.6017,269.50
Interest213.20231.50209.90272.20276.70990.30
Expenditure-4,249.40-8.3%-4,241.20-4,064.70-4,205.30-3,924.70-16,418.70
PBDT000000
EBITDA847.20+13.1%1,020.30833.50835.40748.903,455.30
Depreciation-547.40-513.40-515.30-473-455-1,956.70
EBIT299.80+2.0%506.90318.20362.40293.901,498.60
PBT127.60+31.7%247.500171.3096.90447.90
Tax9.20-48.9016-38.50-7.70-79.10
Equity814.80810.5000668.50810.50
OPM2.915.420.003.902.412.59
Net Profit136.80+53.4%198.60-51.80132.8089.20368.80
NPM3.124.35-1.213.032.222.14
EPS0.87+234.6%0.791.080.660.262.82

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue16,927+10.9%15,261.70+3.4%14,755.70+32.1%11,174.20+36.5%8,184+15.2%7,105.80
Other Income342.501,208.20865.50375.90212.70254.50
Total Income17,269.50+4.9%16,469.90+5.4%15,621.20+35.2%11,550.10+37.6%8,396.70+14.1%7,360.30
Expenditure-16,418.70-11.8%-14,679.80-4.9%-14,000.20-37.3%-10,194.60-43.7%-7,095.60-14.0%-6,226
Interest-990.30-897.40-974.40-419-67.60-57.70
PBDT000000
EBITDA3,455.30+9.1%3,166.30-4.0%3,298.70+31.3%2,511.70+27.5%1,970.20+19.2%1,652.60
Depreciation-1,956.70-1,687-1,568.80-1,113.10-814.20-715.10
EBIT1,498.60+1.3%1,479.30-14.5%1,729.90+23.7%1,398.60+21.0%1,156+23.3%937.50
PBT447.90-76.3%1,886.60+17.2%1,609.40+51.2%1,064.10-10.6%1,190+3.8%1,146.90
Tax-79.10-457.20-227.40-254.10-211.50-221.50
Equity810.50600.300000
OPM (%)2.5911.4510.309.2114.1715.58
Net Profit368.80-74.2%1,429.40+10.1%1,297.80+101.8%643-16.7%771.60-8.8%846.20
NPM (%)2.148.688.315.579.1911.50
EPS (Rs)2.82-66.7%8.46-1.1%8.55+120.4%3.88-28.7%5.44-12.8%6.24
CEPS2.828.468.543.875.426.19

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

20
YearTypeAmountEx-Date
2026Final Dividend0.503 Jul 2026
2025Final Dividend0.504 Jul 2025
2024Final Dividend0.505 Jul 2024
2023Final Dividend1.507 Jul 2023
2022Final Dividend0.530 Jun 2022
2019Final Dividend118 Jul 2019
2019Final Dividend0.518 Jul 2019
2018Final Dividend119 Jul 2018
2017Final Dividend120 Jul 2017
2016Interim Dividend517 Mar 2016
2016Interim Dividend509 Apr 2015
2014Final Dividend510 Jul 2014
2013Final Dividend511 Jul 2013
2013Special Dividend2.511 Jul 2013
2012Final Dividend505 Jul 2012
2011Final Dividend307 Jul 2011
2012Interim Dividend1.505 May 2011
2010Final Dividend3.508 Jul 2010
2009Final Dividend308 Jul 2009
2008Final Dividend503 Jul 2008

Bonus

3
YearRatioEx-Date
20191:112 Jun 2019
20172:115 Jun 2017
20081:111 Sep 2008

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers